Colorectal Cancer Update: A CME Audio Series and Activity

STATEMENT OF NEED/TARGET AUDIENCE

Colorectal cancer is among the most common cancers in the United States, and the arena of colorectal cancer treatment continues to evolve. Published results from ongoing clinical trials lead to the emergence of new therapeutic agents and regimens and changes in indications, doses and schedules for existing treatments. In order to offer optimal patient care — including the option of clinical trial participation — the practicing medical oncologist must be well informed of these advances.

To bridge the gap between research and patient care, Colorectal Cancer Update utilizes one-on-one discussions with leading oncology investigators. By providing access to the latest research developments and expert perspectives, this CME activity assists medical oncologists in the formulation of up-to-date clinical management strategies.

GLOBAL LEARNING OBJECTIVES FOR THE 2004 COLORECTAL CANCER UPDATE SERIES

Upon completion of this activity, participants should be able to:

• Critically evaluate the clinical implications of emerging clinical trial data in colorectal cancer treatment.
  
• Counsel patients about the risks and benefits of adjuvant and neoadjuvant chemotherapy.
  
• Develop and explain a management strategy for patients with metastatic colorectal cancer.
  
• Describe ongoing clinical trials in colorectal cancer and counsel appropriately selected patients about the availability of ongoing clinical trials.
  

PURPOSE OF THIS ISSUE OF COLORECTAL CANCER UPDATE

The purpose of Issue 1 of Colorectal Cancer Update is to support these global objectives by offering the perspectives of Drs Ellis, Cunningham and Roh on the integration of emerging clinical research data into the management of colorectal cancer.

ACREDITATION STATEMENT

Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STAT EMENT

Research To Practice designates this educational activity for a maximum of 3 category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent on the activity.